- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | FDA restricts Sarepta's gene therapy Elevidys after Duchenne patient deaths | ||
| Fr | Otsuka's HAE med Dawnzera, Lilly's oral SERD Inluriyo among drugs scoring EU endorsements | ||
| Fr | LB Pharmaceuticals, Celldex hire commercial chiefs as launch plans ramp up | ||
| Fr | Organon and Henlius' Poherdy, first biosimilar to Roche's Perjeta, scores FDA nod | ||
| Fr | Survey reveals 'cardiology deserts' at heart of Amgen-backed campaign | ||
| Fr | Lundbeck disrupts Alkermes' planned $2.1B purchase of Avadel with higher bid | ||
| Fr | Biopharma industry gathers momentum in Q3 | ||
| Fr | Fierce Pharma Asia-Pfizer's PD-1xVEGF trials; ivonescimab's 1st survival win; Lilly's deal spree | ||
| Do | Bavarian Nordic board chair exits in aftermath of failed private equity takeover | ||
| Do | Lilly, Novo shoot down claims of DTC obesity drug partnership with Mangoceuticals | ||
| Do | Kyowa's bet on Kura pays off as partners' oral med for AML subset wins FDA approval | ||
| Do | Boryung breaks ground on penicillin plant expansion in South Korea | ||
| Do | Gilead hails phase 3 victory for single-tablet combo of bictegravir and lenacapavir, preps filings | ||
| Mi | Recall roundup: Fresenius, Sun and Teva among drugmakers pulling products in recent weeks | ||
| Mi | Lundbeck, Otsuka back survey uncovering 'blind spot' around Alzheimer's agitation | ||
| Mi | As pharma sales stagnate, Bayer exec stands firm behind newer meds and latest launch Lynkuet | ||
| Mi | J&J, Legend withdraw ASH abstract assessing Carvykti against Gilead, Arcellx's rival CAR-T | ||
| Di | Lilly stitches 'Queer Eye' star Tan France into Zepbound campaign to unravel obesity stigma | ||
| Di | Bayer celebrates scientific breakthroughs, battles misinformation in US corporate campaign | ||
| Di | With merger in the books, Mallinckrodt and Endo rebrand as Keenova and spin off Par Health | ||
| Mo | Catalent cuts 77 more jobs in Maryland as gene therapy resizing rolls on | ||
| Mo | Sanofi touts mission to 'chase the miracles of science' in new corporate campaign | ||
| Mo | Novo forges partnership with Emcure to expand Wegovy access in India | ||
| Mo | Pfizer's challenge of BridgeBio ads referred to federal agencies | ||
| 07.11. | J&J brings 'invisible illness' IBD out of the shadows with report supporting the power of patient community |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .